Your browser doesn't support javascript.
loading
Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study.
Auvinen, Anssi; Cardis, Elisabeth; Blettner, Maria; Moissonnier, Monika; Sadetzki, Siegal; Giles, Graham; Johansen, Christoffer; Swerdlow, Anthony; Cook, Angus; Fleming, Sarah; Berg-Beckhoff, Gabriele; Iavarone, Ivano; Parent, Marie-Elise; Woodward, Alistair; Tynes, Tore; McBride, Mary; Krewski, Dan; Feychting, Maria; Takebayashi, Toru; Armstrong, Bruce; Hours, Martine; Siemiatycki, Jack; Lagorio, Susanna; Larsen, Signe Benzon; Schoemaker, Minouk; Klaeboe, Lars; Lönn, Stefan; Schüz, Joachim.
Afiliação
  • Auvinen A; Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.
  • Cardis E; STUK-Radiation and Nuclear Safety Authority, Helsinki, Finland.
  • Blettner M; Barcelona Institute of Global Health (ISGlobal), Centre for Research in Environmental Epidemiology, Universitat Pompeu Funebra, Barcelona, Spain.
  • Moissonnier M; CIBER Epidemiologia y Salud Publica, Madrid, Spain.
  • Sadetzki S; University of Mainz, IMBEI, Mainz, Germany.
  • Giles G; International Agency for Research on Cancer, Lyon, France.
  • Johansen C; Gertner Institute, Tel Aviv, Israel.
  • Swerdlow A; Cancer Council Victoria, Melbourne, VIC, Australia.
  • Cook A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Fleming S; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Berg-Beckhoff G; Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
  • Iavarone I; School of Population and Global Health, University of Western Australia, Crawley, WA, Australia.
  • Parent ME; University of Leeds, Leeds, UK.
  • Woodward A; Faculty of Public Health, University of Bielefeld, Germany.
  • Tynes T; Istituto Superiore di Sanità, Rome, Italy.
  • McBride M; INRS Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Université du Québec, Laval, QC, Canada.
  • Krewski D; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Feychting M; National Institute of Occupational Health, Oslo, Norway.
  • Takebayashi T; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Armstrong B; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, ON, Canada.
  • Hours M; Karolinska Institutet, Stockholm, Sweden.
  • Siemiatycki J; Keio University School of Medicine, Tokyo, Japan.
  • Lagorio S; School of Public Health, University of Sydney, Sydney, NSW, Australia.
  • Larsen SB; Université Lyon 1, IFSTTAR, UMRESTTE, Bron, France.
  • Schoemaker M; University of Montreal, Montreal, QC, Canada.
  • Klaeboe L; Istituto Superiore di Sanità, Rome, Italy.
  • Lönn S; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Schüz J; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Int J Epidemiol ; 51(2): 537-546, 2022 05 09.
Article em En | MEDLINE | ID: mdl-34648614
ABSTRACT

BACKGROUND:

Exposure to high doses of ionizing radiation is among the few well-established brain tumour risk factors. We used data from the Interphone study to evaluate the effects of exposure to low-dose radiation from diagnostic radiological examinations on glioma, meningioma and acoustic neuroma risk.

METHODS:

Brain tumour cases (2644 gliomas, 2236 meningiomas, 1083 neuromas) diagnosed in 2000-02 were identified through hospitals in 13 countries, and 6068 controls (population-based controls in most centres) were included in the analysis. Participation across all centres was 64% for glioma cases, 78% for meningioma cases, 82% for acoustic neuroma cases and 53% for controls. Information on previous diagnostic radiological examinations was obtained by interviews, including the frequency, timing and indication for the examinations. Typical brain doses per type of examination were estimated based on the literature. Examinations within the 5 years before the index date were excluded from the dose estimation. Adjusted odds ratios were estimated using conditional logistic regression.

RESULTS:

No materially or consistently increased odds ratios for glioma, meningioma or acoustic neuroma were found for any specific type of examination, including computed tomography of the head and cerebral angiography. The only indication of an elevated risk was an increasing trend in risk of meningioma with the number of isotope scans, but no such trends for other examinations were observed. No gradient was found in risk with estimated brain dose. Age at exposure did not substantially modify the findings. Sensitivity analyses gave results consistent with the main analysis.

CONCLUSIONS:

There was no consistent evidence for increased risks of brain tumours with X-ray examinations, although error from selection and recall bias cannot be completely excluded. A cautious interpretation is warranted for the observed association between isotope scans and meningioma.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neuroma Acústico / Telefone Celular / Glioma / Neoplasias Meníngeas / Meningioma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neuroma Acústico / Telefone Celular / Glioma / Neoplasias Meníngeas / Meningioma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article